Vuzix Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Vuzix Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.24M | Mar 12, 2026 |
| FY2025 | Sep 30, 2025 | $1.16M | Mar 12, 2026 |
| FY2025 | Jun 30, 2025 | $1.30M | Mar 12, 2026 |
| FY2025 | Mar 31, 2025 | $1.58M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.27M | Mar 12, 2026 |
| FY2025 | Sep 30, 2024 | $1.39M | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | $1.09M | Mar 12, 2026 |
| FY2025 | Mar 31, 2024 | $2.00M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.07M | Mar 12, 2026 |
| FY2025 | Sep 30, 2023 | $2.18M | Mar 12, 2026 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.6K | Mar 16, 2018 |
| FY2017 | Sep 30, 2017 | $1.4K | Mar 16, 2018 |
| FY2017 | Jun 30, 2017 | $1.3K | Mar 16, 2018 |
| FY2017 | Mar 31, 2017 | $1.2K | Mar 16, 2018 |
| FY2017 | Dec 31, 2016 | $620 | Mar 16, 2018 |
| FY2017 | Sep 30, 2016 | $583 | Mar 16, 2018 |
| FY2017 | Jun 30, 2016 | $561 | Mar 16, 2018 |
| FY2017 | Mar 31, 2016 | $364 | Mar 16, 2018 |
| FY2017 | Dec 31, 2015 | $2.75M | Mar 16, 2018 |
| FY2015 | Dec 31, 2014 | $3.03M | Mar 30, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $375.0K | Mar 12, 2026 |
| FY2025 | Sep 30, 2025 | ($411.0K) | Mar 12, 2026 |
| FY2025 | Jun 30, 2025 | ($761.0K) | Mar 12, 2026 |
| FY2025 | Mar 31, 2025 | ($265.0K) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($4.95M) | Mar 12, 2026 |
| FY2025 | Sep 30, 2024 | ($260.0K) | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | ($333.0K) | Mar 12, 2026 |
| FY2025 | Mar 31, 2024 | ($53.0K) | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | ($4.25M) | Mar 12, 2026 |
| FY2025 | Sep 30, 2023 | ($238.0K) | Mar 12, 2026 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($8.62M) | Mar 12, 2026 |
| FY2025 | Sep 30, 2025 | ($7.35M) | Mar 12, 2026 |
| FY2025 | Jun 30, 2025 | ($7.67M) | Mar 12, 2026 |
| FY2025 | Mar 31, 2025 | ($8.64M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($13.66M) | Mar 12, 2026 |
| FY2025 | Sep 30, 2024 | ($9.22M) | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | ($40.61M) | Mar 12, 2026 |
| FY2025 | Mar 31, 2024 | ($10.05M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | ($19.88M) | Mar 12, 2026 |
| FY2025 | Sep 30, 2023 | ($10.98M) | Mar 12, 2026 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($32.51M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($73.97M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | ($52.30M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | ($42.23M) | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | ($39.98M) | Apr 15, 2024 |
| FY2021 | Sep 30, 2021 | ($10.37M) | Oct 25, 2022 |
| FY2021 | Jun 30, 2021 | ($9.21M) | Oct 25, 2022 |
| FY2021 | Mar 31, 2021 | ($9.09M) | Oct 25, 2022 |
| FY2022 | Dec 31, 2020 | ($19.13M) | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | ($26.57M) | Oct 25, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.63M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $9.63M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $12.34M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $12.68M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $11.67M | Apr 15, 2024 |
| FY2021 | Sep 30, 2021 | $3.40M | Oct 25, 2022 |
| FY2021 | Jun 30, 2021 | $2.72M | Oct 25, 2022 |
| FY2021 | Mar 31, 2021 | $2.21M | Oct 25, 2022 |
| FY2022 | Dec 31, 2020 | $7.57M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $8.90M | Oct 25, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($18.79M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($23.74M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | ($26.28M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | ($24.52M) | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | ($26.98M) | Apr 15, 2024 |
| FY2021 | Sep 30, 2021 | ($18.91M) | Oct 25, 2022 |
| FY2021 | Jun 30, 2021 | ($13.11M) | Oct 25, 2022 |
| FY2021 | Mar 31, 2021 | ($5.92M) | Oct 25, 2022 |
| FY2022 | Dec 31, 2020 | ($13.96M) | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | ($22.36M) | Oct 25, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.01M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.36M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $5.32M | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | $1.72M | Mar 13, 2025 |
| FY2023 | Dec 31, 2021 | $3.81M | Apr 15, 2024 |
| FY2022 | Dec 31, 2020 | $496.6K | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $1.90M | Oct 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.37M | Mar 15, 2021 |
| FY2019 | Dec 31, 2017 | $1.68M | Mar 16, 2020 |
| FY2018 | Dec 31, 2016 | $2.04M | Mar 15, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.07M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $39.41M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $86.15M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $131.07M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $148.47M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $52.47M | Oct 25, 2022 |
| FY2020 | Dec 31, 2019 | $28.45M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $35.13M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $26.83M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $22.35M | Mar 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.39M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.11M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $5.35M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $15.58M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $4.74M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $4.17M | Oct 25, 2022 |
| FY2020 | Dec 31, 2019 | $4.21M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $4.68M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $5.45M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | $4.62M | Mar 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.68M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $37.29M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $80.79M | Mar 12, 2026 |
| FY2025 | Dec 31, 2022 | $115.49M | Mar 12, 2026 |
| FY2024 | Dec 31, 2021 | $143.73M | Mar 13, 2025 |
| FY2023 | Dec 31, 2020 | $48.30M | Apr 15, 2024 |
| FY2022 | Dec 31, 2019 | $24.24M | Mar 1, 2023 |
| FY2021 | Dec 31, 2018 | $30.46M | Oct 25, 2022 |
| FY2020 | Dec 31, 2017 | $21.38M | Mar 15, 2021 |
| FY2019 | Dec 31, 2016 | $17.72M | Mar 16, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2022 | $1.60M | Apr 15, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($399.86M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($367.52M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($293.98M) | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | ($243.84M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($203.07M) | Mar 1, 2023 |
| FY2021 | Sep 30, 2021 | ($191.58M) | Oct 25, 2022 |
| FY2021 | Jun 30, 2021 | ($181.09M) | Oct 25, 2022 |
| FY2021 | Mar 31, 2021 | ($171.85M) | Oct 25, 2022 |
| FY2021 | Dec 31, 2020 | ($162.69M) | Oct 25, 2022 |
| FY2020 | Dec 31, 2019 | ($144.74M) | Mar 15, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.15M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $18.19M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $26.56M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | $72.56M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $120.20M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $36.07M | Oct 25, 2022 |
| FY2020 | Dec 31, 2019 | $10.61M | Mar 15, 2021 |
| FY2020 | Dec 31, 2018 | $17.26M | Mar 15, 2021 |
| FY2020 | Dec 31, 2017 | $14.89M | Mar 15, 2021 |
| FY2019 | Dec 31, 2016 | $14.53M | Mar 16, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $0 | Mar 16, 2018 |
| FY2017 | Dec 31, 2016 | $1.42M | Mar 16, 2018 |
| FY2016 | Dec 31, 2015 | $1.28M | Mar 16, 2017 |
| FY2015 | Dec 31, 2014 | $1.10M | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $269.8K | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $2.78M | Apr 9, 2014 |
| FY2012 | Dec 31, 2011 | $6.00M | Mar 19, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 12, 2026 |
| FY2025 | Sep 30, 2023 | 0 | Mar 12, 2026 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 12, 2026 |
| FY2025 | Sep 30, 2023 | 0 | Mar 12, 2026 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 81.10M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 75.97M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | 64.73M | Mar 13, 2025 |
| FY2023 | Dec 31, 2022 | 63.32M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | 63.67M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 45.65M | Oct 25, 2022 |
| FY2020 | Dec 31, 2019 | 33.13M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | 27.59M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | 24.28M | Mar 15, 2019 |
| FY2017 | Dec 31, 2016 | 19.57M | Mar 16, 2018 |